
Oligosaccharides du lait maternel
Les oligosaccharides du lait humain (HMO) sont des glucides complexes présents dans le lait maternel, essentiels à la santé des nourrissons en favorisant la santé intestinale et en modulant le système immunitaire. Ils sont étudiés pour leurs effets prébiotiques et leurs applications thérapeutiques potentielles dans les formules pour nourrissons et la santé des adultes. CymitQuimica fournit des HMO pour la recherche dans les études du microbiome, la nutrition et la santé des nourrissons.
19 produits trouvés pour "Oligosaccharides du lait maternel"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
2'-Fucosyllactose - Synthetic
CAS :<p>2'-Fucosyllactose (2'-FL) is the most abundant human milk oligosaccharide (HMO) with multiple functions including: acting as a prebiotic, protecting against infections and inflammation, modulating the immune system, supporting brain development, and reducing the risk of necrotizing enterocolitis. The commercial availability of synthetic fucosyllactose is important because HMOs were previously only found at significant levels in human milk, however they are now available in several infant formulas. It has been given Generally Recognized As Safe (GRAS) status and the European Union has approved the use of 2'-Fucosyllactose in infant formula products (Reverri, 2018).</p>Formule :C18H32O15Degré de pureté :(2'-Fucosyllactose) Min. 94.0%Couleur et forme :White PowderMasse moléculaire :488.44 g/molLS-tetrasaccharide c ammonium salt
CAS :<p>Sialylated tetrasaccharide found in human milk, possible health benefits for the neonate by supporting resistance to pathogens, gut maturation, immune function, and cognitive development.</p>Formule :C37H62N2O29•NH3Degré de pureté :Min. 95 Area-%Couleur et forme :White PowderMasse moléculaire :1,015.88 g/molSialylfucosyllacto-N-tetraose
CAS :<p>Sialylfucosyllacto-N-tetraose is a human milk oligosaccharide (HMO) and is present in lower concentrations than 2â²-fucosyllactose. Sialylfucosyllacto-N-tetraose contains both nitrogen and sialic acid in its chemical structure. It has been demostrated that sialylfucosyllacto-N-tetraose in the HMO pool acts as a prebiotic, protects against infections and inflammation, modulates the immune system, supports brain development, and reduces the risk of necrotizing enterocolitis (WiciÅski, 2020).</p>Formule :C43H72N2O33Degré de pureté :Min. 95 Area-%Couleur et forme :PowderMasse moléculaire :1,145.03 g/molLacto-N-neohexaose
CAS :<p>Neutral hexasasaccharide naturally present in human breast milk</p>Formule :C40H68N2O31Degré de pureté :Min. 90 Area-%Couleur et forme :White PowderMasse moléculaire :1,072.96 g/mol6'-Galactosyllactose
CAS :<p>Galactosyllactose attenuated NF-κB inflammatory signaling in human intestinal epithelial cells and in human immature intestine. Thus, galactosyllactoses are strong anti-inflammatory agents in human colostrum and early milk, contributing to innate immune modulation. The potential clinical utility of galactosyllactose warrants investigation.</p>Formule :C18H32O16Degré de pureté :Min. 95 Area-%Couleur et forme :White PowderMasse moléculaire :504.43 g/mol6'-Sialyllactose sodium salt
CAS :<p>6'-Sialyllactose is found in milk with immunoprotective effects against pathogens in newborns and aids development and maturation of the immune system and gut microbiota. It suppresses adhesion and infectivity of bacteria and viruses, such as influenza viruses, HIV-1 and rotaviruses and inhibits binding of cholera toxin.</p>Formule :C23H38NO19NaDegré de pureté :Min. 90 Area-%Couleur et forme :White PowderMasse moléculaire :655.53 g/molLS-tetrasaccharide a
CAS :<p>Sialylated tetrasaccharide found in human milk. Possible health benefits for the neonate, by supporting resistance to pathogens, gut maturation, immune function, and cognitive development.</p>Formule :C37H62N2O29Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :998.88 g/molHuman milk neutral tetrasaccharides
<p>Mainly a mixture of Lacto-N-tetraose, Lacto-N-neo-tetraose, Lactodifucotetraose</p>Degré de pureté :Min. 95%Couleur et forme :PowderMonofucosyl (1-3)-iso-lacto-N-octaose
CAS :Monofucosyl (1-3)-iso-lacto-N-octaose is an HMO oligosaccharide.Formule :C60H101N3O45Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :1,584.44 g/molLacto-N-fucopentaose V
CAS :<p>Human milk oligosaccharide; binds cholera toxin TcdA</p>Formule :C32H55NO25Degré de pureté :Min. 80%Couleur et forme :PowderMasse moléculaire :853.77 g/mol2'-O-Fucosyllactulose
CAS :<p>2'-O-Fucosyllactulose is a modified carbohydrate that has been synthesized from a natural source. It is an oligosaccharide that contains the monosaccharide, fucose. This product can be used in the synthesis of polysaccharides and glycosylation reactions. 2'-O-Fucosyllactulose has been methylated, fluorinated, and glycosylated, which makes it suitable for use as a sugar in biotechnology applications.</p>Formule :C18H32O15Degré de pureté :Min. 90 Area-%Couleur et forme :PowderMasse moléculaire :488.44 g/molTrifucosyl-p-lacto-N-hexaose
CAS :<p>Trifucosyl-p-lacto-N-hexaose is a complex carbohydrate that has been modified by methylation and glycosylation. It is a synthesized sugar that may be used as a pharmaceutical agent or as an additive in food products. Trifucosyl-p-lacto-N-hexaose has been modified using Click chemistry and fluorination, which have been shown to increase the purity of this compound. This product has a high degree of purity, as it is synthesized from pure materials.</p>Formule :C58H98N2O43Degré de pureté :Min. 90 Area-%Couleur et forme :SolidMasse moléculaire :1,511.39 g/molp-Lacto-N-hexaose
CAS :<p>Neutral hexasasaccharide naturally present in human breast milk</p>Formule :C40H68N2O31Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :1,072.96 g/molLacto-N-tetraose - 90%
CAS :<p>Core human milk oligosaccharide</p>Formule :C26H45NO21Degré de pureté :Min. 90 Area-%Couleur et forme :White PowderMasse moléculaire :707.63 g/mol3'-Sialyl-N-acetyllactosamine sodium salt
CAS :<p>Component of glycoproteins and glycolipids expressed in antigens and receptors of proteins, bacteria and viruses. Found in the free form in human biofluids, including urine and milk - preventing adhesion of bacteria to urinary epithelium and inhibiting enteric pathogens respectively. An efficient inhibitor of neutrophil-activating protein of H.pylori (HPNAP)-mediated neutrophil activation.</p>Formule :C25H42N2O19·NaDegré de pureté :Min. 95%Couleur et forme :White Off-White PowderMasse moléculaire :697.59 g/molLS-tetrasaccharide b
CAS :<p>Sialylated tetrasaccharide found in human milk, possible health benefits for the neonate by supporting resistance to pathogens, gut maturation, immune function, and cognitive development.</p>Formule :C37H61N2O29•NH4Degré de pureté :Min. 95 Area-%Couleur et forme :White PowderMasse moléculaire :1,015.92 g/molLacto-N-neotetraose
CAS :<p>Lacto-N-neotetraose (LNnT) is a neutral and abundant human milk oligosaccharide (HMO), composed of four sugar molecules. It supports the infant's gut microbiota development and provides protection against infectious diseases. LNnT like many other HMOs offers great interest for the studies of baby milk formula.</p>Formule :C26H45NO21Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :707.63 g/molLS-tetrasaccharide a sodium
CAS :<p>Sialylated tetrasaccharide found in human milk.Possible health benefits for the neonate, by supporting resistance to pathogens, gut maturation, immune function, and cognitive development.</p>Formule :C37H61N2O29•NaHDegré de pureté :Min. 95 Area-%Couleur et forme :PowderMasse moléculaire :1,020.87 g/mol3'-Sialyllacto-N-neotetraose
CAS :<p>Component of human milk; antimicrobial activity against bacterial pathogens</p>Formule :C37H62N2O29Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :998.88 g/mol
